About Oral Cancer Foundation News Team - A

This author has not yet filled in any details.
So far Oral Cancer Foundation News Team - A has created 2444 blog entries.

Disadvantages of using chewing tobacco to quit smoking

Source: www.helium.com Author: Dawn Hawkins If you are a smoker who is trying to quit smoking, there are several ways in which you might attempt to attain the goal. Chewing tobacco might seem like one of the best answers to your problem. The goal is to stop the smoke from going into your lungs, right? That is partially true. There are many advantages of using chewing tobacco to quit smoking, but there are great disadvantages to it also. Disadvantages of using chewing tobacco to quit smoking: Teeth- Your teeth become discolored much faster when you chew tobacco in order to try to quit smoking. Your teeth will suffer discoloring when you smoke cigarettes, but chewing tobacco comes into direct contact with the tooth's surface making them more susceptible to staining. Spitting- When you chew tobacco, you also have to spit it somewhere. This can be a problem if someone takes away the container that you are spitting in. It is also not a very attractive thing to do. You have to carry something around with you at all times that contains your already chewed tobacco and your spit. That is another thing that is definitely not attractive. Accidents- When you have a bottle that you are using to spit the tobacco into, there is a good chance your or someone else will accidentally drink the mixture thinking it is something else. chewing tobacco has a very foul taste when combined with spit. It is also very unhealthy to swallow. That [...]

2010-07-05T17:34:30-07:00July, 2010|Oral Cancer News|
Read More

Betel nut, oral cancer pilot study for Saipan, Guam now underway

Source: www.saipantribune.com Author: Moneth Deposa A betel nut and oral cancer pilot study will be conducted on Saipan and Guam beginning this year. The study hopes to gather baseline date to develop protocols for studying oral precancerous lesions and other health risks among betel nut users in Micronesia. University of Guam epidemiologist Dr. Yvette Paulino, co-leader in the pilot study, will work with Dr. Suzanne Murphy from the Cancer Research Center of Hawaii in the pilot study. In a presentation to members of the Commonwealth Cancer Association last week, Dr. Paulino disclosed that oral cancer is the sixth leading cancer worldwide, but ranks in the Top 3 cancers in countries where there are betel nut/areca nut chewers. Betel nut, she said, is apparently a misnomer. The nut itself is more accurately called “areca nut” and “betel” refers to the leaf that is sometimes used with the nut. “Betel quid” refers to the mixture of nut and leaf. The three-year pilot study aims to collect information on betel nut/areca nut use among 300 study participants in Guam and on Saipan and members of their families. In the course of the study, oral examinations and biopsies will be performed as needed, health risks will be measured, and associations of duration, frequency, and type of betel nut/areca nut use with oral pre-cancers and health risks will be studied. Dr. Paulino said that betel nut/areca nut is considered a human carcinogen. She revealed that betel nut chewing has been shown to be associated with [...]

2010-07-05T17:25:11-07:00July, 2010|Oral Cancer News|
Read More

Oral cancer treatment and reconstruction

Source: www.cancernewstoday.com Author: staff Trace the steps of Carolyn Coogan, a patient who discovered she had oral cancer and her subsequent treatment options as Dr. Neal Futran, director of otolaryngology head and neck surgery at the University of Washington Medical Center, leads a discussion of the processes. Discover how Coogans treatment crossed medical disciplines as it involved surgeries to remove cancer, reconstruct the jaw and install the dental prosthesis.

2010-07-04T14:53:01-07:00July, 2010|Oral Cancer News|
Read More

Researchers develop high-precision cancer tests using patients’ saliva

Source: mdn.mainichi.jp Author: staff Researchers develop high-precision cancer tests using patients' saliva Researchers have developed a high-precision method to diagnose three types of cancer from saliva, enabling patients to undergo tests without physical discomfort. The method, announced at the current meeting of the international Metabolomics Society in the Netherlands, was developed by a team including researchers from Keio University's Institute for Advanced Biosciences. "We want to proceed with analysis of other types of cancer and other illnesses, and put this to practical use," university research lecturer Masahiro Sugimoto said. Sugimoto said the University of California, Los Angeles, which is participating in the research, collected saliva from 215 people aged 11 to 87. Eighty-seven of the patients were healthy, 18 had cancer of the pancreas, 30 had breast cancer, 69 had oral cancer, and 11 had gum disease. Researchers analyzed the 500 or so types of substances found in their saliva, and identified 54 substances whose concentrations differed markedly between healthy people and people with three specific types of cancer. Since concentrations of a single substance varied among the subjects, the researchers combined several substances and then examined the concentrations. As a result, the team found that they could identify patients with cancer of the pancreas with 99 percent accuracy by examining five substances in their saliva including the amino acid phenylalanine. Using similar tests, the researchers were able to identify breast cancer with 95 percent accuracy and oral cancer with 80 percent accuracy. Sugimoto said that research to diagnose cancer [...]

2010-07-01T14:59:39-07:00July, 2010|Oral Cancer News|
Read More

Is drinking coffee as good as it is made out to be?

Source: healthcare.tmcnet.com Author: Mini Swam Studies about the drinking habits of coffee and tea drinkers have always managed to excite attention, and with more and more studies being conducted, newer information has surfaced. Nine existing studies were looked at and analyzed. Researchers determined how much of coffee was consumed by more than 5,000 cancer patients and 9,000 healthy people. In the latest study conducted, researchers have found that the incidence of head and neck cancers appeared to decrease when four or more cups of coffee were drunk every day. The risk in such cases decreased by 39 percent in respect of oral cavity and pharynx cancers. However, it did not appear to have any effect on laryngeal cancer. By and large, the results seemed really positive, but Mia Hashibe, lead researcher and an assistant professor in the department of family and preventive medicine at the University of Utah, cautioned against drinking lots of coffee. Looking at the results from a logical point of view, Hashibe pointed out that the main risk factors for oral cancers were smoking and drinking alcohol, and the best way to prevent such cancers would be to stay away from smoking and drinking alcohol. Further Hashibe indicated that it would be highly misleading to suggest that drinking lots of coffee without taking into account the real risk factors could prevent people from getting those cancers. Different people metabolize caffeine or coffee in different ways, and it was important to realize this fact before indulging in lots [...]

2010-06-30T04:15:26-07:00June, 2010|Oral Cancer News|
Read More

The ultimate telemedicine tweak to dSLRs: cancer detection

Source: www.medgadget.com Author: staff Photography-loving doctors now have more reasons to love their digital cameras. MacGyvers at Rice University and MD Anderson Cancer Center have cleverly engineered your everyday dSLR into a portable, high-resolution fiber-optic fluorescence imaging system that can detect cancer in-vivo. In this month's PLoS ONE, they showed off the prowess of their camera system retrofitted with a LED light, an objective lens, a fiber-optic bundle in capturing sub-cellular images non-invasively and in real-time. In field tests of a fluorescence-labeled oral cancer cell culture, a surgically-resected human tissue specimen with dysplastic and cancerous regions, and a healthy human subject in vivo, the fiber-optic microscope resolved individual nuclei in all specimens and tissues imaged to distinguish qualitatively and quantitatively between normal, precancerous and/or cancerous tissues. Portable and inexpensive at $2000 all-together, the clever device may be a useful tool to assist in the identification of early neoplastic changes in epithelial tissues in spartan clinical settings where MacGyver himself may have been.

2010-06-29T18:24:20-07:00June, 2010|Oral Cancer News|
Read More

Get moving: cancer survivors urged to exercise

Source: apnews.myway.com Author: Lauran Neergaard New guidelines are urging survivors to exercise more, even - hard as it may sound - those who haven't yet finished their treatment. There's growing evidence that physical activity improves quality of life and eases some cancer-related fatigue. More, it can help fend off a serious decline in physical function that can last long after therapy is finished. Consider: In one year, women who needed chemotherapy for their breast cancer can see a swapping of muscle for fat that's equivalent to 10 years of normal aging, says Dr. Wendy Demark-Wahnefried of the University of Alabama at Birmingham. In other words, a 45-year-old may find herself with the fatter, weaker body type of a 55-year-old. Scientists have long advised that being overweight and sedentary increases the risk for various cancers. Among the nation's nearly 12 million cancer survivors, there are hints - although not yet proof - that people who are more active may lower risk of a recurrence. And like everyone who ages, the longer cancer survivors live, the higher their risk for heart disease that exercise definitely fights. The American College of Sports Medicine convened a panel of cancer and exercise specialists to evaluate the evidence. Guidelines issued this month advise cancer survivors to aim for the same amount of exercise as recommended for the average person: about 2 1/2 hours a week. Patients still in treatment may not feel up to that much, the guidelines acknowledge, but should avoid inactivity on their good [...]

2010-06-28T20:08:45-07:00June, 2010|Oral Cancer News|
Read More

Quantifying the effects of promoting smokeless tobacco as a harm reduction strategy in the USA

Source: http://tobaccocontrol.bmj.com Authors: Adrienne B Mejia et al. Background: Snus (a form of smokeless tobacco) is less dangerous than cigarettes. Some health professionals argue that snus should be promoted as a component of a harm reduction strategy, while others oppose this approach. Major US tobacco companies (RJ Reynolds and Philip Morris) are marketing snus products as cigarette brand line extensions. The population effects of smokeless tobacco promotion will depend on the combined effects of changes in individual risk with population changes in tobacco use patterns. Objective: To quantitatively evaluate the health impact of smokeless tobacco promotion as part of a harm reduction strategy in the US. Methods: A Monte Carlo simulation of a decision tree model of tobacco initiation and use was used to estimate the health effects associated with five different patterns of increased smokeless tobacco use. Results: With cigarette smoking having a health effect of 100, the base case scenario (based on current US prevalence rates) yields a total health effect of 24.2 (5% to 95% interval 21.7 to 26.5) and the aggressive smokeless promotion (less cigarette use and increased smokeless, health-concerned smokers switching to snus, smokers in smokefree environments switching to snus) was associated with a health effect of 30.4 (5% to 95% interval 25.9 to 35.2). The anticipated health effects for additional scenarios with lower rates of smokeless uptake also overlapped with the base case. Conclusions: Promoting smokeless tobacco as a safer alternative to cigarettes is unlikely to result in substantial health benefits at a population [...]

2010-06-28T13:19:14-07:00June, 2010|Oral Cancer News|
Read More

U.S. scores dead last again in healthcare study

Source: www.reuters.com Author: edited by Sandra Maler and Cynthia Osterman The United States ranked last when compared to six other countries -- Britain, Canada, Germany, Netherlands, Australia and New Zealand, the Commonwealth Fund report found. "As an American it just bothers me that with all of our know-how, all of our wealth, that we are not assuring that people who need healthcare can get it," Commonwealth Fund president Karen Davis told reporters in a telephone briefing. Previous reports by the nonprofit fund, which conducts research into healthcare performance and promotes changes in the U.S. system, have been heavily used by policymakers and politicians pressing for healthcare reform. Davis said she hoped health reform legislation passed in March would lead to improvements. The current report uses data from nationally representative patient and physician surveys in seven countries in 2007, 2008, and 2009. It is available here. In 2007, health spending was $7,290 per person in the United States, more than double that of any other country in the survey. Australians spent $3,357, Canadians $3,895, Germans $3,588, the Netherlands $3,837 and Britons spent $2,992 per capita on health in 2007. New Zealand spent the least at $2,454. This is a big rise from the Fund's last similar survey, in 2007, which found Americans spent $6,697 per capita on healthcare in 2005, or 16 percent of gross domestic product. "We rank last on safety and do poorly on several dimensions of quality," Schoen told reporters. "We do particularly poorly on going without care [...]

2010-06-27T14:42:29-07:00June, 2010|Oral Cancer News|
Read More

Role of esophageal stents in the nutrition support of patients with esophageal malignancy

Source: ncp.sagepub.com Authors: Matthew Bower, MD et al. Endoluminal stents are commonly used for palliative treatment of dysphagia in patients with advanced esophageal malignancies. The most frequently used esophageal stents are self-expanding metal stents. Removable self-expanding plastic stents have recently been used in the management of esophageal cancer patients treated with curative intent. Esophageal stents effectively alleviate dysphagia in most patients, and stent placement is associated with a low rate of complications. This article reviews the use of self-expanding esophageal stents in patients with esophageal cancer. Nutrition considerations following stent placement are addressed. Authors: Matthew Bower, MD, Whitney Jones, MD, Ben Vessels, MD, Charles Scoggins, MD, MBA, Robert Martin, MD, PhD Authors' affiliation: Division of Surgical Oncology, Department of Surgery, and James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, Kentucky

2010-06-27T14:34:57-07:00June, 2010|Oral Cancer News|
Read More
© - The Oral Cancer Foundation - Head & Neck Cancer IRS 501(c)3 Charity - 3419 Via Lido #205, Newport Beach, CA 92663 | Disclaimer / Privacy Policy
Go to Top